Valuation : GENFIT

Market Cap 706M 819M 664M 605M 1.14B 77.71B 1.14B 7.85B 3.06B 39.53B 3.07B 3.01B 131B P/E 2026 *
36.4x
P/E 2027 * 93.8x
Enterprise Value 655M 760M 616M 561M 1.06B 72.09B 1.06B 7.29B 2.84B 36.67B 2.85B 2.79B 122B EV / Sales 2026 *
6.54x
EV / Sales 2027 * 5.16x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day+2.12%
1 week+1.41%
Current month+1.98%
1 month+2.71%
3 months+69.45%
6 months+62.20%
Current year+173.88%
1 week 13.84
Extreme 13.84
14.98
1 month 12.74
Extreme 12.74
15.2
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 2019-09-15
Director of Finance/CFO 52 2021-04-21
Chief Tech/Sci/R&D Officer - 2025-11-26
Director TitleAgeSince
Chairman 70 2017-06-15
Director/Board Member 54 1999-09-14
Director/Board Member 58 2017-06-15
Date Insider Type Main position Quantity % Market Cap. Importance
3/5/26 Exercice

Chief Operating Officer

11,250 0.0225%
3/5/26 Exercice

Chief Operating Officer

7,083 0.0142%
3/5/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%+1.41%+329.17%+343.69% 819M
+0.83%-1.09%+3.16%+17.38% 49.74B
+2.09%-0.71%+452.73%+498.77% 44.98B
-1.09%-0.41%+35.40%+15.17% 42.52B
-0.26%-4.71%+17.19%+71.67% 40.78B
-0.48%-0.84%+16.25%+49.80% 32.89B
-1.06%+2.87% - - 17.09B
-1.81%-5.02%+22.65%+113.24% 16.28B
+0.84%-0.93%+17.49%+26.96% 14.4B
-2.05%-5.14%+72.89%+34.69% 13.48B
Average +0.03%-2.33%+107.44%+130.15% 27.3B
Weighted average by Cap. +0.19%-2.27%+98.23%+123.05%

Financials

2026 *2027 *
Net sales 100M 116M 94.25M 85.86M 161M 11.02B 162M 1.11B 434M 5.61B 436M 427M 18.59B 124M 144M 117M 106M 200M 13.65B 201M 1.38B 537M 6.94B 540M 528M 23.02B
Net income 22.88M 26.52M 21.52M 19.61M 36.87M 2.52B 37.07M 254M 99.02M 1.28B 99.58M 97.42M 4.25B 6.8M 7.88M 6.4M 5.83M 10.96M 748M 11.02M 75.62M 29.43M 381M 29.6M 28.96M 1.26B
Net Debt -51.12M -59.26M -48.08M -43.81M -82.37M -5.62B -82.82M -568M -221M -2.86B -222M -218M -9.49B -66.17M -76.71M -62.25M -56.71M -107M -7.28B -107M -736M -286M -3.7B -288M -282M -12.28B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
26-09-02 14.44 +2.27% 53,952
26-09-01 €14.12 -0.14% 146,344
26-08-31 €14.14 -1.67% 264,283
26-08-28 €14.38 -0.96% 294,675
26-08-27 €14.52 +2.11% 171,883
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.12EUR
Average target price
15.90EUR
Spread / Average Target
+12.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock